Interestingly, EIF1AX was found to harbor heterozygous mutations in papillary carcinomas, the most common thyroid cancer, and in ovarian carcinoma with a worse prognosis when coupled with mutations of the Ras family [106,107]. Here, EIF1AX is linked to thyroid cancer.